Profil bibliographique

Vinay Kumar Venishetty

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

18Publications signalées

618Citations signalées

1Affiliations récentes

Institutions déclarées

Domaines associés

Advancements in Transdermal Drug DeliveryAdvanced Drug Delivery SystemsMalaria Research and ControlAntibiotics Pharmacokinetics and EfficacyHelminth infection and control

Publications récentes

Accès ouvert 2025 article

Pharmacokinetics, safety and efficacy of an optimized dose of artemether–lumefantrine in the treatment of acute uncomplicated Plasmodium falciparum malaria in neonates and infants of less than 5 kg body weight: a multicentre, open-label, single-arm phase 2/3 study (CALINA)

Gildas Wounounou, Alfred B. Tiono, Bernhards Ogutu, Christine Manyando et autres

2 citationsTropical Medicine and Health

Accès ouvert 2025 article

Physiologically based pharmacokinetic modelling to predict artemether and lumefantrine exposure in neonates weighing less than 5 kg treated with artemether–lumefantrine to supplement the clinical data from the CALINA study

Helen Gu, Nada Abla, Vinay Kumar Venishetty, Birgit Schoeberl et autres

2 citationsTropical Medicine and Health

2024 article

Importance of tailored non-clinical safety testing of novel antimalarial drugs: Industry best-practice

Philip Hewitt, Andreas Hartmann, Belén Tornesi, Sandrine Ferry-Martin et autres

4 citationsRegulatory Toxicology and Pharmacology

Accès ouvert 2024 article

First-in-human, randomized, double-blind, placebo-controlled, single and multiple ascending doses clinical study to assess the safety, tolerability, and pharmacokinetics of cipargamin administered intravenously in healthy adults

Vinay Kumar Venishetty, Jean Lecot, Jie Zhang, William Prince

5 citationsAntimicrobial Agents and Chemotherapy

Accès ouvert 2023 article

Effects of triclabendazole and its metabolite exposure on the heart‐rate–corrected QT intervals: A randomized, placebo‐ and positive‐controlled thorough QT study in healthy individuals

William Prince, Vinay Kumar Venishetty, Jean Lecot, Kasra Shakeri‐Nejad et autres

2 citationsClinical and Translational Science

Accès ouvert 2021 article

Efficacy of Cipargamin (KAE609) in a Randomized, Phase II Dose-Escalation Study in Adults in Sub-Saharan Africa With Uncomplicated Plasmodium falciparum Malaria

E. Schmitt, Gilles Ndayisaba, Adoke Yeka, Kwaku Poku Asante et autres

89 citationsClinical Infectious Diseases

2021 book-chapter

Global impact of human fasciolosis.

Preetam Gandhi, Richa Chandra, E. Schmitt, Chien‐Wei Chen et autres

1 citationCABI eBooks

Accès ouvert 2019 article

Triclabendazole in the treatment of human fascioliasis: a review

Preetam Gandhi, E. Schmitt, Chien‐Wei Chen, Sanjay Samantray et autres

128 citationsTransactions of the Royal Society of Tropical Medicine and Hygiene

Accès ouvert 2019 article

A First-in-Human Study To Assess the Safety and Pharmacokinetics of LYS228, a Novel Intravenous Monobactam Antibiotic in Healthy Volunteers

Megan Boysen‐Osborn, Noah Stachulski, Haiying Sun, Johanne Blais et autres

6 citationsAntimicrobial Agents and Chemotherapy

2017 article

Identification of Novel Agents for the Treatment of Brain Metastases of Breast Cancer

Vinay Kumar Venishetty, Werner J. Geldenhuys, Tori B. Terell-Hall, Jessica I. Griffith et autres

3 citationsCurrent Cancer Drug Targets

2012 article

β-Hydroxybutyric acid grafted solid lipid nanoparticles: A novel strategy to improve drug delivery to brain

Vinay Kumar Venishetty, Ramakrishna Samala, Rojarani Komuravelli, Madhusudana Kuncha et autres

73 citationsNanomedicine Nanotechnology Biology and Medicine

2012 article

Increased brain uptake of docetaxel and ketoconazole loaded folate-grafted solid lipid nanoparticles

Vinay Kumar Venishetty, Rojarani Komuravelli, Madhusudana Kuncha, Ramakrishna Sistla et autres

103 citationsNanomedicine Nanotechnology Biology and Medicine

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.